Abstract:Abstract Background Abnormal expression of suppressor of cytokine signaling (SOCS) proteins regulates tumor angiogenesis and development in cancers. In this study, we aimed to perform a comprehensive bioinformatic analysis of SOCS proteins in breast invasive carcinoma (BRCA). Methods The gene expression, methylation level, copy number, protein expression and patient survival data related to SOCS family members in BRCA patients were obtained from the following databases: Oncomine, The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), PCViz, cBioPortal and Kaplan-Meier plotter. Correlation analyses, identification of interacting genes and construction of regulatory networks were performed by functional and pathway enrichment analyses, weighted gene coexpression network analysis (WGCNA) and gene set enrichment analysis (GSEA). Results Data related to 1109 BRCA tissues and 113 normal breast tissue samples were extracted from the TCGA database. SOCS2 and SOCS3 exhibited significantly lower mRNA expression levels in BRCA tissues than in normal tissues. BRCA patients with high mRNA levels of SOCS3 ( p < 0.01) and SOCS4 ( p < 0.05) were predicted to have significantly longer overall survival (OS) times. Multivariate analysis showed that SOCS3 was an independent prognostic factor for OS. High mRNA expression levels of SOCS2 ( p < 0.001), SOCS3 (p < 0.001), and SOCS4 ( p < 0.01), and a low expression level of SOCS5 (p < 0.001) were predicted to be significantly associated with better recurrence-free survival (RFS). Multivariate analysis showed that SOCS2 was an independent prognostic factor for RFS. Lower expression levels of SOCS2 and SOCS3 were observed in patients with tumors of more advanced clinical stage ( p < 0.05). Functional and pathway enrichment analyses, together with WGCNA and GSEA, showed that SOCS3 and its interacting genes were significantly involved in the JAK-STAT signaling pathway, suggesting that JAK-STAT signaling might play a critical role in BRCA angiogenesis and development. Western blot results showed that overexpression of SOCS3 inhibited the activity of the JAK-STAT signaling pathway in vitro. Conclusions SOCS family proteins play a very important role in BRCA. SOCS3 may be a prognostic factor and SOCS2 may be a potential therapeutic target in breast cancer.

Reciprocal Regulation Of Socs1 And Socs3 Enhances Resistance To Ionizing Radiation In Glioblastoma Multiforme

Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma

Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme

Oncogenic role of microRNA-19b-3p-mediated SOCS3 in glioma through activation of JAK-STAT pathway

SIRT2 Suppression Increases Responsiveness of Glioma Cells to Radiation Treatment Via FoxO3a Inhibition

Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer

Apobec3g Acts As A Therapeutic Target In Mesenchymal Gliomas By Sensitizing Cells To Radiation-Induced Cell Death

The role of STAT3 activation in modulating the immune microenvironment of GBM

SOX21 suppresses GBM growth by repressing AP-1 regulated target genes

Diagnostic Significance of Suppressor of Cytokine Signalling 3 (SOCS3) Methylation and Its Correlation with IDH1 Mutation in Chinese Glioma Patients

Upregulation of DNA Metabolism-Related Genes Contributes to Radioresistance of Glioblastoma.

Tumour-promoting role of SOCS1 in colorectal cancer cells

Glioma Stem-Like Cells Evade Interferon Suppression Through MBD3/NuRD Complex-Mediated STAT1 Downregulation

Inhibition of SOCS6 Confers Radioresistance in Esophageal Squamous Cell Carcinoma.

Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.

ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation

The Role and Gene Expression Profile of SOCS3 in Colorectal Carcinoma.

SOX9-PDK1 Axis is Essential for Glioma Stem Cell Self-Renewal and Temozolomide Resistance.

Restoration of SOCS3 Suppresses Human Lung Adenocarcinoma Cell Growth by Downregulating Activation of Erk1/2, Akt Apart from STAT3

Knockdown of SOX2OT Inhibits the Malignant Biological Behaviors of Glioblastoma Stem Cells Via Up-Regulating the Expression of Mir-194-5p and Mir-122

High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML